Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.47
-0.03 (-2.00%)
At close: Jun 05, 2025, 3:59 PM
1.48
0.68%
After-hours: Jun 05, 2025, 07:44 PM EDT
-2.00%
Bid 1.25
Market Cap 105.77M
Revenue (ttm) 26.86M
Net Income (ttm) -224.19M
EPS (ttm) -3.14
PE Ratio (ttm) -0.47
Forward PE -0.76
Analyst Hold
Ask 1.63
Volume 1,002,691
Avg. Volume (20D) 828,157
Open 1.50
Previous Close 1.50
Day's Range 1.34 - 1.60
52-Week Range 1.01 - 11.91
Beta 1.61

About ZNTL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZNTL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ZNTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
4 months ago
-21.25%
Zentalis Pharmaceuticals shares are trading lower.... Unlock content with Pro Subscription
4 months ago
-1.08%
Zentalis Pharmaceuticals shares are trading higher after the company announced that the FDA has granted Fast Track Designation to azenosertib for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.